Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Wegener's franulomatosis; risk factor for major infections Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Risk factors for major infections in Wegener’s franulomatosis: Analysis of 113 patients
Annals of Rheumatic Diseases, 06/03/08
Print     Email This Article     Save in My Library   Free Abstract
Charlier C et al. - Cyclophosphamide and corticosteroids were associated with higher risk of infection in Wegener’s granulomatosis (WG) patients. Despite systematic cotrimoxazole prophylaxis, major infections, mostly bronchopneumonias and herpes zoster recurrences, were still common.

Methods
  • Study to characterize major infectious complications and analyze potential risk factors in WG pts
  • Data from 113 WG pts (69 men) followed at least once between Jan 1984 and March 2006 were analyzed retrospectively

Results
  • 35 pts (mean age at WG diagnosis: 50.2y) developed 53 major infections
  • Half of the major infectious episodes occurred within the 3 yrs after WG diagnosis
  • 7% pts died, with 2% infection-related deaths
  • Pts diagnosed with WG before 1996 had a higher rate of infections than those diagnosed later
  • Cyclophosphamide and corticosteroids were independently associated with higher risk of major infection
  • All pts treated since 1993 received anti-pneumocystosis prophylaxis

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.